0001209191-22-021393.txt : 20220328
0001209191-22-021393.hdr.sgml : 20220328
20220328203010
ACCESSION NUMBER: 0001209191-22-021393
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220324
FILED AS OF DATE: 20220328
DATE AS OF CHANGE: 20220328
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hu Cynthia W.
CENTRAL INDEX KEY: 0001364709
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40360
FILM NUMBER: 22777117
MAIL ADDRESS:
STREET 1: 6440 WINDERMERE
CITY: NORTH BETHESDA
STATE: MD
ZIP: 20852
FORMER NAME:
FORMER CONFORMED NAME: Wong Cynthia
DATE OF NAME CHANGE: 20060601
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Mind Medicine (MindMed) Inc.
CENTRAL INDEX KEY: 0001813814
STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A1
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1166 ALBERNI STEET
STREET 2: SUITE 1604
CITY: VANCOUVER
STATE: A1
ZIP: V6E 3Z3
BUSINESS PHONE: (212) 220-6633
MAIL ADDRESS:
STREET 1: 1166 ALBERNI STEET
STREET 2: SUITE 1604
CITY: VANCOUVER
STATE: A1
ZIP: V6E 3Z3
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-03-24
0
0001813814
Mind Medicine (MindMed) Inc.
MNMD
0001364709
Hu Cynthia W.
C/O MIND MEDICINE (MINDMED), INC.
ONE WORLD TRADE CENTER, SUITE 8500
NEW YORK
NY
10007
0
1
0
0
Chief Legal Officer&Secretary
Subordinate Voting Shares
2022-03-24
4
A
0
1200000
0.00
A
1200000
D
Stock Option (Right to Buy)
1.18
2022-03-24
4
A
0
1560000
0.00
A
2027-03-23
Subordinate Voting Shares
1560000
1560000
D
These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one subordinate voting share of the Issuer. Of these RSUs, 25% shall vest on December 6, 2022, with 1/48th vesting at the end of each month thereafter for the succeeding 36 months, subject, to the Reporting Person providing continuous service to the Issuer on each such vesting date.
The option grant has an exercise price of $1.48 Canadian Dollars. This represents the exercise price in United States Dollars.
25% of the shares underlying the option shall vest and become exercisable on December 6, 2022; the remaining shares underlying the option shall vest and become exercisable with 1/48th of the total shares vesting at the end of each month thereafter for the succeeding 36 months, subject to the Reporting Person providing continuous service to the Issuer on each such vesting date.
/s/ Robert Barrow, Attorney-in-Fact
2022-03-28